Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy

Since prostate cancer (PCa) was described as androgen-dependent, the androgen receptor (AR) has become the mainstay of its systemic treatment: androgen deprivation therapy (ADT). Although, through recent years, more potent drugs have been incorporated, this chronic AR signaling inhibition inevitably...

Description complète

Détails bibliographiques

Auteurs principaux:	Belén Congregado Ruiz, Inés Rivero Belenchón, Guillermo Lendínez Cano, Rafael Antonio Medina López
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-04-01
Collection:	Biomedicines
Sujets:	castration-resistant prostate cancer antiandrogen therapy resensitizing to antiandrogens bipolar antiandrogen therapy androgen receptor
Accès en ligne:	https://www.mdpi.com/2227-9059/11/4/1105
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!